March 19 (Reuters) – U.S. Health and Human Services chief counselor Chris Klomp said on Thursday the government has begun to read-in pharmaceutical companies on efforts to write into law President Donald Trump’s most-favored-nation deals, aimed at aligning U.S. prescription drug costs with those in other wealthy countries.
(Reporting by Mariam Sunny in Bengaluru and Michael Erman in New York; Editing by Shilpi Majumdar)
Brought to you by www.srnnews.com
